BlackRock, Inc. 13D and 13G filings for Castle Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-08 4:32 pm Purchase |
2024-06-30 | 13G | Castle Biosciences, Inc. CSTL |
BLACKROCK INC BLK |
3,044,973 11.000% |
761,774 (+33.36%) |
Filing |
| 2024-01-25 1:48 pm Purchase |
2023-12-31 | 13G | Castle Biosciences, Inc. CSTL |
BLACKROCK INC BLK |
2,283,199 8.500% |
159,511 (+7.51%) |
Filing |
| 2023-02-03 4:27 pm Purchase |
2022-12-31 | 13G | Castle Biosciences, Inc. CSTL |
BLACKROCK INC BLK |
2,123,688 8.100% |
322,301 (+17.89%) |
Filing |
| 2022-02-04 4:12 pm Purchase |
2021-12-31 | 13G | Castle Biosciences, Inc. CSTL |
BLACKROCK INC BLK |
1,801,387 7.100% |
1,801,387 (New Position) |
Filing |